Association between living with children and adherence to highly active antiretroviral therapy in the women's interagency HIV study

Pediatrics

Volumn 121, Issue 4, 2008, Pages

  Merenstein, Daniel J ^a   Schneider, Michael F ^b   Cox, Christopher ^b   Schwartz, Rebecca ^c   Weber, Kathleen ^d   Robison, Esther ^e   Gandhi, Monica ^f   Richardson, Jean ^g   Plankey, Michael W ^h  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d Jr Hospital of Cook County   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

Author keywords

Adherence; Children; HAART; HIV

Indexed keywords

ABACAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TENOFOVIR;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; FAMILY LIFE; FEMALE; GROUPS BY AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOTHER; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CHILD PARENT RELATION; DRUG ADMINISTRATION; FOLLOW UP; HOSPITALIZATION; INCIDENCE; MALE; METHODOLOGY; MOTHER CHILD RELATION; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STATISTICS;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MOTHER-CHILD RELATIONS; MULTIVARIATE ANALYSIS; PARENTING; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 42949166830     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1586     Document Type: Article

References (40)

1. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450-454
2. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22-29
3. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853-860
4. Schneider MF, Gange SJ, Williams CM, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS. 2005;19(17):2009-2018
5. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288(15):1909-1914
6. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14): 1775-1779
7. Grumbach K, Bodenheimer T. A primary care home for Americans: putting the house in order. JAMA. 2002;288(7): 889-893
8. Kerr T, Walsh J, Lloyd-Smith E, Wood E. Measuring adherence to highly active antiretroviral therapy: implications for research and practice. Curr HIV/AIDS Rep. 2005;2(4):200-205
9. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S123-S127
10. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS. 2003;17(4):169-177
11. Bartlett JA, Fath MJ, Demasi R, et al. An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. AIDS. 2006;20(16):2051-2064
12. Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366(9483): 378-384
13. Nieuwkerk PT, Sprangers MA, Burger DM, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med. 2001;161(16):1962-1968
14. Kirstein LM, Greenblatt RM, Anastos K, et al. Prevalence and correlates of highly active antiretroviral therapy switching in
15. the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2002;29(5):495-503
16. Schuman P, Ohmit S, Cohen M, et al. Prescription of and adherence to antiretroviral therapy among woman with AIDS. AIDS Behav. 2001;5(4):371-378
17. Cook JA, Cohen MH, Grey D, et al. Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women. Am J Public Health. 2002;92(1):82-87
18. Wilson TE, Barron Y, Cohen M, et al. Adherence to antiretro- viral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34(4):529-534
19. Malone SB, Osborne JJ. Improving treatment adherence in drug abusers who are HIV-positive. Lippincotts Case Manag. 2000;5(6):236-245; quiz 245-237
20. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30
21. Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006; 368(9534):489-504
22. Majumdar D. An overview of the recent trends in HIV/AIDS in the United States. Indian J Public Health. 2006;50(1):28-30
23. Monasch R, Mahy M. Young people: the centre of the HIV epidemic. World Health Organ Tech Rep Ser. 2006;938:15-41; discussion 317-341
24. The Henry J. Kaiser Family Foundation. Women and HIV/ AIDS in the United States. Available at: www.kff.org/hivaids/ upload/6092-04.pdf. Accessed March 1, 2007
25. Murphy DA, Marelich WD, Dello Stritto ME, Swendeman D, Witkin A. Mothers living with HIV/AIDS: mental, physical, and family functioning. AIDS Care. 2002;14(5):633-644
26. Mellins CA, Kang E, Leu CS, Havens JF, Chesney MA. Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care STDS. 2003;17(8):407-416
27. Murphy DA, Greenwell L, Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health. 2002;36(1):97-111
28. Murphy DA, Steers WN, Dello Stritto ME. Maternal disclosure of mothers' HIV serostatus to their young children. J Fam Psychol. 2001;15(3):441-450
29. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9(2):117-125
30. Bacon MC, von Wyl V, Alden C, et al. The Women's Inter- agency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12(9): 1013-1019
31. Department of Health and Human Services/Henry J Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV- infected adults and adolescents, December 1, 2007. Available at: www.hivatis.org/Guidelines/GuidelineDetail.aspx? MenuItem= Guidelines&Search=Off&GuidelineID=7&ClassID= 1. Accessed July 28, 2007
32. Diggle P, Heagerty P, Liang K-Y, Zeger S. Analysis of Longitudinal Data. 2nd ed. New York, NY: Oxford University Press; 2002
33. Smith MY, Feldman J, Kelly P, DeHovitz JA, Chirgwin K, Minkoff H. Health-related quality of life of HIV-infected women: evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20. Qual Life Res. 1996;5(1):47-55
34. Laine C, Newschaffer CJ, Zhang D, Cosler L, Hauck WW, Turner BJ. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol. 2000;95(2): 167-173
35. Zorrilla CD, Santiago LE, Knubson D, et al. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV. Cell Mol Biol (Noisy-le-grand). 2003;49(8):1187-1192
36. Demas PA, Webber MP, Schoenbaum EE, et al. Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study. Pediatrics. 2002; 110(3). Available at: www.pediatrics.org/cgi/content/full/110/
37. 3/e35
38. Ickovics JR, Wilson TE, Royce RA, et al. Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. J Acquir Immune Defic Syndr. 2002;30(3):311-315
39. Committee on Hospital Care. American Academy of Pediatrics. Family-centered care and the pediatrician's role. Pediatrics. 2003;112(3 pt 1):691-697
40. Gordis L. Epidemiology. 2nd ed. Baltimore, MD: WB Saunders Company; 2000